In this Newshour Special Edition, Navika Kumar speaks to India’s top endocrinologist Dr Ambrish Mithal on the country’s fast-growing weight loss obsession. From Ozempic to Mounjaro, are these new-age ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

Jim Corbett National Park, India's oldest, is more than just tigers. Originally Hailey National Park in 1936, it became Jim ...

Mounjaro has released once-weekly injections that are helpful in managing type 2 diabetes along with showing remarkable ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Eli Lilly's obesity and Type 2 diabetes drug, Mounjaro, has gained approval from the Indian drug control authority for its ...

Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following ...

With the launch of Wegovy by Danish pharmaceutical giant Novo Nordisk and US major Eli Lilly’s Mounjaro already in ...

Eli Lilly and Novo Nordisk intensify their weight-loss drug rivalry in India as rising demand and looming generics reshape a ...